[go: up one dir, main page]

HK40113753A - Pharmaceutical formulation - Google Patents

Pharmaceutical formulation Download PDF

Info

Publication number
HK40113753A
HK40113753A HK62025101567.8A HK62025101567A HK40113753A HK 40113753 A HK40113753 A HK 40113753A HK 62025101567 A HK62025101567 A HK 62025101567A HK 40113753 A HK40113753 A HK 40113753A
Authority
HK
Hong Kong
Prior art keywords
pharmaceutical formulation
formulation
pharmaceutical
Prior art date
Application number
HK62025101567.8A
Other languages
Chinese (zh)
Inventor
Bindhumadhavan GURURAJAN
Emeric Reynaud
Vincent ROGUE
Rohit Lowalekar
Yogesh Pawar
Tushar SAWAI
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of HK40113753A publication Critical patent/HK40113753A/en

Links

HK62025101567.8A 2022-02-21 2023-02-20 Pharmaceutical formulation HK40113753A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN202211009181 2022-02-21

Publications (1)

Publication Number Publication Date
HK40113753A true HK40113753A (en) 2025-02-21

Family

ID=

Similar Documents

Publication Publication Date Title
EP4190310A4 (en) Stable pharmaceutical preparation
CA3265980A1 (en) Upadacitinib formulation
IL314206A (en) Pharmaceutical formulation
EP4205765A4 (en) Stable pharmaceutical preparation
CA3266275A1 (en) Pharmaceutical formulation
HK40113753A (en) Pharmaceutical formulation
HK40103575A (en) Pharmaceutical formulation
HK40097541A (en) Pharmaceutical formulation
HK40090037A (en) Pharmaceutical formulation
HK40090038A (en) Pharmaceutical formulation
AU2024275492A1 (en) Pharmaceutical formulations
HK40100860A (en) Pharmaceutical formulations
HK40122488A (en) Pharmaceutical composition comprising centanafadine
HK40091202A (en) Pharmaceutical formulations
HK40089663A (en) Pharmaceutical formulations
HK40085410A (en) Pharmaceutical formulations
AU2023903165A0 (en) Tablet formulation
HK40080656A (en) Pharmaceutical formulations
HK40121850A (en) Pharmaceutical composition
AU2020903780A0 (en) Pharmaceutical formulations
AU2020903781A0 (en) Pharmaceutical formulations
HK40102489A (en) X842 formulation
HK40102489B (en) X842 formulation
CA3261419A1 (en) Pharmaceutical composition comprising centanafadine
HK40117282A (en) Tafamidis pharmaceutical compositions